Literature DB >> 9275177

Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53.

M M Sugrue1, D Y Shin, S W Lee, S A Aaronson.   

Abstract

The p53 tumor suppressor gene has been shown to play an important role in determining cell fate. Overexpression of wild-type p53 in tumor cells has been shown to lead to growth arrest or apoptosis. Previous studies in fibroblasts have provided indirect evidence for a link between p53 and senescence. Here we show, using an inducible p53 expression system, that wild-type p53 overexpression in EJ bladder carcinoma cells, which have lost functional p53, triggers the rapid onset of G1 and G2/M growth arrest associated with p21 up-regulation and repression of mitotic cyclins (cyclin A and B) and cdc2. Growth arrest in response to p53 induction became irreversible within 48-72 h, with cells exhibiting morphological features as well as specific biochemical and ultrastructural markers of the senescent phenotype. These findings provide direct evidence that p53 overexpression can activate the rapid onset of senescence in tumor cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9275177      PMCID: PMC23243          DOI: 10.1073/pnas.94.18.9648

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  p53, the cellular gatekeeper for growth and division.

Authors:  A J Levine
Journal:  Cell       Date:  1997-02-07       Impact factor: 41.582

2.  Proliferative capacity and DNA content of aging human diploid cells in culture: a cytophotometric and autoradiographic analysis.

Authors:  R Yanishevsky; M L Mendelsohn; B H Mayall; V J Cristofalo
Journal:  J Cell Physiol       Date:  1974-10       Impact factor: 6.384

3.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

4.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

5.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

6.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

7.  H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer.

Authors:  S W Lee
Journal:  Nat Med       Date:  1996-07       Impact factor: 53.440

8.  Genetic determinants of p53-induced apoptosis and growth arrest.

Authors:  K Polyak; T Waldman; T C He; K W Kinzler; B Vogelstein
Journal:  Genes Dev       Date:  1996-08-01       Impact factor: 11.361

9.  Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence.

Authors:  J Bond; M Haughton; J Blaydes; V Gire; D Wynford-Thomas; F Wyllie
Journal:  Oncogene       Date:  1996-11-21       Impact factor: 9.867

10.  p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells.

Authors:  X Chen; L J Ko; L Jayaraman; C Prives
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

View more
  78 in total

1.  p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.

Authors:  L Fang; G Li; G Liu; S W Lee; S A Aaronson
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

2.  The G(2) checkpoint is maintained by redundant pathways.

Authors:  T M Passalaris; J A Benanti; L Gewin; T Kiyono; D A Galloway
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  The involvement of p53 in dopamine-induced apoptosis of cerebellar granule neurons and leukemic cells overexpressing p53.

Authors:  D Daily; A Barzilai; D Offen; A Kamsler; E Melamed; I Ziv
Journal:  Cell Mol Neurobiol       Date:  1999-04       Impact factor: 5.046

Review 4.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

5.  SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D.

Authors:  X Lin; P Nelson; I H Gelman
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

6.  PML is induced by oncogenic ras and promotes premature senescence.

Authors:  G Ferbeyre; E de Stanchina; E Querido; N Baptiste; C Prives; S W Lowe
Journal:  Genes Dev       Date:  2000-08-15       Impact factor: 11.361

7.  p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop.

Authors:  Pat P Ongusaha; Jong-il Kim; Li Fang; Tai W Wong; George D Yancopoulos; Stuart A Aaronson; Sam W Lee
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

8.  Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype.

Authors:  M Toyota; M Ohe-Toyota; N Ahuja; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

9.  Induction of the small heat shock protein alphaB-crystallin by genotoxic stress is mediated by p53 and p73.

Authors:  Joseph R Evans; Joshua D Bosman; Lauren Brown-Endres; Fruma Yehiely; Vincent L Cryns
Journal:  Breast Cancer Res Treat       Date:  2009-09-24       Impact factor: 4.872

10.  p53 prevents immature escaping from cell cycle G2 checkpoint arrest through inhibiting cdk2-dependent NF-Y phosphorylation.

Authors:  Un-Jung Yun; Heui-Dong Park; Deug Y Shin
Journal:  Cancer Res Treat       Date:  2006-12-31       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.